CD274 and hypothyroidism: Hypothyroidism is widely acknowledged as the most common immune-related endocrine toxicity, which occurs in approximately 30%–40% of anti-PD-1/PD-L1-treated patients (Larkin et al., 2019; Wright et al., 2021).